14Dec/14
Living-Heart-Inspiration-125x50

The Loving Heart Behind the Living Heart Project

By Daniel R. Matlis

“The 3DExperience” was at the core of Dassault Systèmes user’s conference in Las Vegas last month. “We are at the 4th horizon of Dassault Systèmes,” proclaimed Monica Menghini, EVP Corporate Strategy, Industry and Marketing at Dassault Systèmes. “We called it the 3DExperience, because 3D is the legacy of Dassault Systèmes, but Experience is [not only] our future, it is your future because today consumers buy experience, not products.”

Keeping with the Experience theme, the names of Dassault Systèmes’ products were noticeably absent from the main stage. Instead, Dassault’s executives and customers shared their experiences with the company’s products and the impact they are making on their customer’s experience.

For me, the highlight of the 3DS Experience was Dr. Steven Levine’s presentation recounting the journey of “Building a Living Heart: How Technology is Transforming Lives.” Levine is Senior Director of SIMULIA Portfolio Management at Dassault Systèmes. If you keep reading, you will find out that he is much more than that. Continue reading

27Nov/14
Global-Innovation-150

Med-Tech CEO’s turn to Emerging Markets for Double-Digit Growth

By Daniel R. Matlis

Med-Tech Companies are poised to capitalize on global opportunities; however, they must balance the risks and rewards of globalization. When Axendia’s research team surveyed Med-Tech executives we found that:Global-Innovation

  • 73% expect an increasing rate of new product introductions in emerging markets
  • 72% are globalizing to improve the rate of product innovation
  • 65% see the global regulatory environment as the top business threat
  • 55% are globalizing to speed up time-to-market

But you don’t have to take our word for it.  CEOs from leading Med-Tech companies are turning to emerging markets for double digit growth. Continue reading

21Oct/14
Camstar-Siemens

Siemens’ Acquisition of Camstar Could Help Med-Tech Companies Close the Loop on Product Quality

By Daniel R. Matlis

Siemens’ acquisition of Camstar could help Medical Technology (Med-Tech) companies improve product quality by providing integrated solutions to manage Medical Devices across the Total Product Life Cycle (TPLC). The Camstar acquisition builds on Siemens’ industrial digitalization strategy by broadening its integrated product development and production automation. Continue reading

12Oct/14
Image courtesy of Siemens

J&J – Siemens Collaborate on Personalized Medical Device Platform

By Daniel R. Matlis

Modern Healthcare is shifting to personalized care tailored to each patient’s anatomy, therapeutic regimen and expectations. As a result, Med-Tech companies are seeking new ways to develop, design and manufacture more personalized devices that improve patient outcomes while increasing quality of care and reducing Healthcare costs.

To address this need, Siemens and Johnson & Johnson’s DePuy Synthes Joint Reconstruction division leveraged the Personalized Product Innovation platform to develop the TRUMATCH® Personalized Solutions. Continue reading